National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 5 of 1994) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 5 of 1994

I, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Human Services and Health and Delegate of the Minister for Health, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

1.  This Declaration shall come into operation on 1 April 1994.

2.  The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

“Banish”

Benzoin

Butyl Monoester Polymer with Ethanol

Butyl Monoester Polymer with Isopropyl Alcohol

“Cancel”

Carmellose Sodium with Pectin and Gelatin

Chloroquine Sulfate

Dimethicone

Ergometrine Maleate with Oxytocin (synthetic)

Isopropyl Monoester Polymer with Isopropyl Alcohol

Octoxinol

“Odorgon”

Oxytocin (synthetic)

Polyisobutylene

Povidone and Vinyl Acetate Copolymer

Sterculia

“Super Banish”

Triamterene

Dated this seventeenth day of March 1994.

D. GRAHAM

Assistant Secretary

Pharmaceutical Benefits Branch

Department of Human Services and Health

Delegate of the Minister for Health